Results 121 to 130 of about 59,669 (311)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine

open access: yesCase Reports in Cardiology, 2016
We present a case of a syncopal episode resulting from significant QT interval prolongation in a patient on hydroxychloroquine for the treatment of systemic lupus erythematosus and end stage renal disease.
John P. O’Laughlin   +2 more
doaj   +1 more source

Screening for hydroxychloroquine retinal toxicity: Is it necessary? [PDF]

open access: bronze, 1990
C D Morsman   +4 more
openalex   +1 more source

Erythematoviolaceous Papules and Plaques on Sun‐Exposed Areas

open access: yes
JEADV Clinical Practice, EarlyView.
Ana C. Martín‐Zamora   +3 more
wiley   +1 more source

Retinal toxicity in long-term hydroxychloroquine treatment [PDF]

open access: green, 1996
Myron Mavrikakis   +4 more
openalex   +1 more source

Malignancies and immunoglobulin G4‐related disease

open access: yesRheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source

Influence of hydroxychloroquine on the bioavailability of oral metoprolol [PDF]

open access: green, 2000
Mika Somer   +5 more
openalex   +1 more source

Kuldeep Kumar's second contribution to the ‘First Discussion Meeting on Statistical Aspects of the Covid‐19 Pandemic’

open access: yes, 2022
Journal of the Royal Statistical Society: Series A (Statistics in Society), Volume 185, Issue 4, Page 1834-1835, October 2022.
Kuldeep Kumar
wiley   +1 more source

Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis

open access: yesRheumatology &Autoimmunity, EarlyView.
Recent multi‐omics studies have demonstrated that belimumab specifically targets naïve B cells and a subset of memory B cells. This observation is consistent with belimumab's established efficacy and safety profile. Abstract Belimumab is an antibody targeting the cytokine B‐cell activating factor (BAFF), which is crucial for B cell differentiation, and
Keishi Fujio   +5 more
wiley   +1 more source

The prophylactic effect of hydroxychloroquine on the severity of COVID-19 infection in an asymptomatic population: A randomized clinical trial

open access: yesSocial Determinants of Health
Background: Laboratory and observational data suggest that hydroxychloroquine (HCQ) has biological activity against SARS-CoV-2, potentially permitting its use for disease prevention.
Arezoo Chouhdari
doaj   +1 more source

Home - About - Disclaimer - Privacy